Track topics on Twitter Track topics that are important to you
(MedPage Today) -- Phase I trial in Crohn's disease patients shows full healing
TiGenix NV granted Takeda Pharmaceutical Co. Ltd. exclusive rights to develop and commercialize Cx601 in all territories outside of the US for perianal fistulas in patients with Crohn's disease.
Patients undergoing melanoma screening and surveillance should also undergo a screening of the perianal area for melanocytic nevi, which were associated with atypical nevi on other areas of the body, ...
In addition, severity of perianal Crohn's disease was assessed at baseline and all study visits with the Perianal Disease Activity Index (PDAI). In the mITT Read more...
Cx601 is an effective and safe treatment for complex perianal fistulas in patients with Crohn's disease who did not respond to conventional or biological treatments, or both.
Japanese company Takeda Pharmaceutical and Belgium-based TiGenix have entered into an ex-US licence, development and marketing agreement for Cx601 to treat complex perianal fistulas in patients with C...
Takeda Pharmaceutical Company Limited and TiGenix NV have announced that the 24-week results of the Phase 3 ADMIRE-CD trial investigating Cx601 have been published in The Lancet . Cx601 is a suspensio...
New videos will help improve understanding of inhaled drug product testing
Perianal fistula formation is a rare complication in children after rectal biopsy. Perianal fistula may become difficult to treat; therefore a lot of surgical options are present. One of these options...
Perianal fistulas are distressing for the patient and sometimes a challenge for the surgeon. Different methods for the treatment of perianal fistulas have a range of success rates and use of the cutti...
The incidence of rectovaginal fistula in women with Crohn's disease has been reported to be 3-10 %. Although rectovaginal fistulas can be managed medically and surgically, they have high rates of rec...
Gallstone ileus is a rare cause of intestinal obstruction (1-4%). It results from the migration of a gallstone through a bilio-enteric fistula. Treatment begins with fluid therapy, followed by enterol...